mRNA and Antisense biotech - attracting the large fund managers and defining 2020
As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...
mRNA and Antisense biotech - attracting the large fund managers and defining 2020
Ionis Pharmaceuticals - A force for life
mRNA and RNA biotechnology – “The software of life”
Australian biotech companies becoming global players
Antisense Therapeutics Limited dual-lists in Europe